Brass Tax Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$778K Buy
3,360
+55
+2% +$11.2K 0.13% 84
2025
Q2
$613K Buy
3,305
+238
+8% +$44.2K 0.12% 93
2025
Q1
$643K Buy
3,067
+4
+0.1% +$778 0.14% 83
2024
Q4
$544K Buy
3,063
+15
+0.5% +$2.76K 0.11% 90
2024
Q3
$602K Buy
3,048
+979
+47% +$183K 0.13% 81
2024
Q2
$355K Buy
2,069
+240
+13% +$39.8K 0.15% 82
2024
Q1
$333K Buy
+1,829
New +$315K 0.17% 75

Other funds holding ABBV

Brass Tax Wealth Management's ABBV Position: Q3 2025 in Review

Brass Tax Wealth Management increased its AbbVie (ABBV) stake by 1.7% in Q3 2025, buying an estimated $11.2K and bringing the position to 3,360 shares worth $778K. The position accounts for 0.13% of the portfolio, ranked #84.

Brass Tax Wealth Management first reported a position in ABBV in Q1 2024 and has held it in 7 quarters since. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Brass Tax Wealth Management held 3,360 shares of AbbVie worth $778K as of Q3 2025.
  • Brass Tax Wealth Management bought 55 AbbVie shares in Q3 2025, an estimated $11.2K.
  • AbbVie made up 0.13% of Brass Tax Wealth Management's portfolio in Q3 2025, its #84 holding.
  • Brass Tax Wealth Management first reported a position in AbbVie in Q1 2024 and has held it in 7 quarters since.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Brass Tax Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.